From Recipe to Dinner: Business Model Portfolios in the European Biopharmaceutical Industry

This article builds on the analogy between the business model concept and a recipe to discuss the concept of a business model portfolio (which we analogise as a dinner). In this context, we view analogies as concise, shorthand ways to describe important concepts and propose principles to organise ne...

Full description

Saved in:
Bibliographic Details
Published in:Long range planning 2010-04, Vol.43 (2), p.431-447
Main Authors: Sabatier, Valérie, Mangematin, Vincent, Rousselle, Tristan
Format: Article
Language:English
Subjects:
Biotechnology industry
Business models
Interdependence
Long term planning
Strategic management
Studies
Citations: Items that this one cites
Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
cited_by cdi_FETCH-LOGICAL-c430t-65aa75779808ec2deeb19664257a45b1d3fb90923b11ac883dfd7486d288a2e73
cites cdi_FETCH-LOGICAL-c430t-65aa75779808ec2deeb19664257a45b1d3fb90923b11ac883dfd7486d288a2e73
container_end_page 447
container_issue 2
container_start_page 431
container_title Long range planning
container_volume 43
creator Sabatier, Valérie
Mangematin, Vincent
Rousselle, Tristan
description This article builds on the analogy between the business model concept and a recipe to discuss the concept of a business model portfolio (which we analogise as a dinner). In this context, we view analogies as concise, shorthand ways to describe important concepts and propose principles to organise new ways to make money in existing activities. Considering the different business models of four European biotechnology companies, we explore the their business model portfolios, defined as the range of different ways they deliver value to their customers to ensure both their medium term viability and future development. A firm's portfolio can help balance the levels of promise and interdependency with other firms of its different business models, and help it articulate and finance its activities in the medium run to ensure idiosyncrasy to protect its future health.
doi_str_mv 10.1016/j.lrp.2010.02.001
format article
fullrecord <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_746007261</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><els_id>S0024630110000075</els_id><sourcerecordid>2035803231</sourcerecordid><originalsourceid>FETCH-LOGICAL-c430t-65aa75779808ec2deeb19664257a45b1d3fb90923b11ac883dfd7486d288a2e73</originalsourceid><addsrcrecordid>eNp9kE9LJDEQxYMoOLp-AG_Bi6ceK-meJK2n9d-uoCiiJw8hk1Rjhp6kTboFv70ZZk8e9lJFwe89Xj1CjhnMGTBxtpr3aZhzKDfwOQDbITOmZF2VwXfJDIA3laiB7ZODnFdQCGj5jLzdprimz2j9gHSM9NqHgOmcXk7ZB8yZPkSHPX2Kaexi72OmPtDxHenNlOKAJtBLH4d3k9bG4jR6a3p6F9yUx_T1i-x1ps949G8fktfbm5erv9X945-7q9_3lW1qGCuxMEYupGwVKLTcIS5ZK0TDF9I0iyVzdbdsS9h6yZixStWuc7JRwnGlDEdZH5LTre-Q4seEedRrny32vQkYp6xlIwAkF6yQJz_IVZxSKOF0MeNtI9TGjm0hm2LOCTs9JL826Usz0Juy9UqXsvWmbA1clyqL5mKrwfLnp8eks_UYLDqf0I7aRf8f9TdEWIa6</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>288294687</pqid></control><display><type>article</type><title>From Recipe to Dinner: Business Model Portfolios in the European Biopharmaceutical Industry</title><source>ScienceDirect Freedom Collection</source><creator>Sabatier, Valérie ; Mangematin, Vincent ; Rousselle, Tristan</creator><creatorcontrib>Sabatier, Valérie ; Mangematin, Vincent ; Rousselle, Tristan</creatorcontrib><description>This article builds on the analogy between the business model concept and a recipe to discuss the concept of a business model portfolio (which we analogise as a dinner). In this context, we view analogies as concise, shorthand ways to describe important concepts and propose principles to organise new ways to make money in existing activities. Considering the different business models of four European biotechnology companies, we explore the their business model portfolios, defined as the range of different ways they deliver value to their customers to ensure both their medium term viability and future development. A firm's portfolio can help balance the levels of promise and interdependency with other firms of its different business models, and help it articulate and finance its activities in the medium run to ensure idiosyncrasy to protect its future health.</description><identifier>ISSN: 0024-6301</identifier><identifier>EISSN: 1873-1872</identifier><identifier>DOI: 10.1016/j.lrp.2010.02.001</identifier><identifier>CODEN: LRPJA4</identifier><language>eng</language><publisher>London: Elsevier Ltd</publisher><subject>Biotechnology industry ; Business models ; Interdependence ; Long term planning ; Strategic management ; Studies</subject><ispartof>Long range planning, 2010-04, Vol.43 (2), p.431-447</ispartof><rights>2010 Elsevier Ltd</rights><rights>Copyright Pergamon Press Inc. Apr-Jun 2010</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c430t-65aa75779808ec2deeb19664257a45b1d3fb90923b11ac883dfd7486d288a2e73</citedby><cites>FETCH-LOGICAL-c430t-65aa75779808ec2deeb19664257a45b1d3fb90923b11ac883dfd7486d288a2e73</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>314,780,784,27922,27923</link.rule.ids></links><search><creatorcontrib>Sabatier, Valérie</creatorcontrib><creatorcontrib>Mangematin, Vincent</creatorcontrib><creatorcontrib>Rousselle, Tristan</creatorcontrib><title>From Recipe to Dinner: Business Model Portfolios in the European Biopharmaceutical Industry</title><title>Long range planning</title><description>This article builds on the analogy between the business model concept and a recipe to discuss the concept of a business model portfolio (which we analogise as a dinner). In this context, we view analogies as concise, shorthand ways to describe important concepts and propose principles to organise new ways to make money in existing activities. Considering the different business models of four European biotechnology companies, we explore the their business model portfolios, defined as the range of different ways they deliver value to their customers to ensure both their medium term viability and future development. A firm's portfolio can help balance the levels of promise and interdependency with other firms of its different business models, and help it articulate and finance its activities in the medium run to ensure idiosyncrasy to protect its future health.</description><subject>Biotechnology industry</subject><subject>Business models</subject><subject>Interdependence</subject><subject>Long term planning</subject><subject>Strategic management</subject><subject>Studies</subject><issn>0024-6301</issn><issn>1873-1872</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2010</creationdate><recordtype>article</recordtype><recordid>eNp9kE9LJDEQxYMoOLp-AG_Bi6ceK-meJK2n9d-uoCiiJw8hk1Rjhp6kTboFv70ZZk8e9lJFwe89Xj1CjhnMGTBxtpr3aZhzKDfwOQDbITOmZF2VwXfJDIA3laiB7ZODnFdQCGj5jLzdprimz2j9gHSM9NqHgOmcXk7ZB8yZPkSHPX2Kaexi72OmPtDxHenNlOKAJtBLH4d3k9bG4jR6a3p6F9yUx_T1i-x1ps949G8fktfbm5erv9X945-7q9_3lW1qGCuxMEYupGwVKLTcIS5ZK0TDF9I0iyVzdbdsS9h6yZixStWuc7JRwnGlDEdZH5LTre-Q4seEedRrny32vQkYp6xlIwAkF6yQJz_IVZxSKOF0MeNtI9TGjm0hm2LOCTs9JL826Usz0Juy9UqXsvWmbA1clyqL5mKrwfLnp8eks_UYLDqf0I7aRf8f9TdEWIa6</recordid><startdate>20100401</startdate><enddate>20100401</enddate><creator>Sabatier, Valérie</creator><creator>Mangematin, Vincent</creator><creator>Rousselle, Tristan</creator><general>Elsevier Ltd</general><general>Pergamon Press Inc</general><scope>AAYXX</scope><scope>CITATION</scope><scope>7QO</scope><scope>8FD</scope><scope>FR3</scope><scope>P64</scope></search><sort><creationdate>20100401</creationdate><title>From Recipe to Dinner: Business Model Portfolios in the European Biopharmaceutical Industry</title><author>Sabatier, Valérie ; Mangematin, Vincent ; Rousselle, Tristan</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c430t-65aa75779808ec2deeb19664257a45b1d3fb90923b11ac883dfd7486d288a2e73</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2010</creationdate><topic>Biotechnology industry</topic><topic>Business models</topic><topic>Interdependence</topic><topic>Long term planning</topic><topic>Strategic management</topic><topic>Studies</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Sabatier, Valérie</creatorcontrib><creatorcontrib>Mangematin, Vincent</creatorcontrib><creatorcontrib>Rousselle, Tristan</creatorcontrib><collection>CrossRef</collection><collection>Biotechnology Research Abstracts</collection><collection>Technology Research Database</collection><collection>Engineering Research Database</collection><collection>Biotechnology and BioEngineering Abstracts</collection><jtitle>Long range planning</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Sabatier, Valérie</au><au>Mangematin, Vincent</au><au>Rousselle, Tristan</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>From Recipe to Dinner: Business Model Portfolios in the European Biopharmaceutical Industry</atitle><jtitle>Long range planning</jtitle><date>2010-04-01</date><risdate>2010</risdate><volume>43</volume><issue>2</issue><spage>431</spage><epage>447</epage><pages>431-447</pages><issn>0024-6301</issn><eissn>1873-1872</eissn><coden>LRPJA4</coden><abstract>This article builds on the analogy between the business model concept and a recipe to discuss the concept of a business model portfolio (which we analogise as a dinner). In this context, we view analogies as concise, shorthand ways to describe important concepts and propose principles to organise new ways to make money in existing activities. Considering the different business models of four European biotechnology companies, we explore the their business model portfolios, defined as the range of different ways they deliver value to their customers to ensure both their medium term viability and future development. A firm's portfolio can help balance the levels of promise and interdependency with other firms of its different business models, and help it articulate and finance its activities in the medium run to ensure idiosyncrasy to protect its future health.</abstract><cop>London</cop><pub>Elsevier Ltd</pub><doi>10.1016/j.lrp.2010.02.001</doi><tpages>17</tpages><oa>free_for_read</oa></addata></record>
fulltext fulltext
identifier ISSN: 0024-6301
ispartof Long range planning, 2010-04, Vol.43 (2), p.431-447
issn 0024-6301
1873-1872
language eng
recordid cdi_proquest_miscellaneous_746007261
source ScienceDirect Freedom Collection
subjects Biotechnology industry
Business models
Interdependence
Long term planning
Strategic management
Studies
title From Recipe to Dinner: Business Model Portfolios in the European Biopharmaceutical Industry
url http://sfxeu10.hosted.exlibrisgroup.com/loughborough?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-13T22%3A27%3A23IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=From%20Recipe%20to%20Dinner:%20Business%20Model%20Portfolios%20in%20the%20European%20Biopharmaceutical%20Industry&rft.jtitle=Long%20range%20planning&rft.au=Sabatier,%20Val%C3%A9rie&rft.date=2010-04-01&rft.volume=43&rft.issue=2&rft.spage=431&rft.epage=447&rft.pages=431-447&rft.issn=0024-6301&rft.eissn=1873-1872&rft.coden=LRPJA4&rft_id=info:doi/10.1016/j.lrp.2010.02.001&rft_dat=%3Cproquest_cross%3E2035803231%3C/proquest_cross%3E%3Cgrp_id%3Ecdi_FETCH-LOGICAL-c430t-65aa75779808ec2deeb19664257a45b1d3fb90923b11ac883dfd7486d288a2e73%3C/grp_id%3E%3Coa%3E%3C/oa%3E%3Curl%3E%3C/url%3E&rft_id=info:oai/&rft_pqid=288294687&rft_id=info:pmid/&rfr_iscdi=true